CMXHF News and Press, Csl Ltd From 09/13/20

Investment Thesis CSL Limited ( CSLLY ) has yet to fully recover from the plasma shortages experienced during the lockdowns. The impact on production is likely to materialize just as elective surgeries resume. The influenza vaccine sales can pick up the slack as fears mount over a flu outb...

The following slide deck was published by CSL Limited in conjunction with their 2020 Q4 earnings Read more ...

CSL Limited (CSLLY) Q4 2020 Earnings Conference Call August 18, 2020, 09:00 PM ET Company Participants Mark Dehring - VP, IR Paul Perreault - CEO David Lamont - CFO Conference Call Participants Chris Cooper - Goldman Sachs Lyanne Harrison - Bank of America David Low - J...

UniQure (NASDAQ: QURE ) inks an agreement with CSL Limited ( OTCPK:CMXHF ) unit CSL Behring granting the latter global rights to gene therapy etranacogene dezaparvovec for the treatment of hemophilia B. More news on: uniQure N.V., CSL Limited, CSL Limited, Healthcare stocks news, Stocks ...

There are many levels to the coronavirus pandemic and a massive effort is underway to find a vaccine and treatments. Genetic Engineering News summarised 161+ candidates. The US clinical trials website indicates 1,915 trials underway using the keyword COVID-19 (June 3, 2020). The common c...

I keep a close eye on recent ETF launches to see not only what new opportunities are available to investors but also what strategies the 'sell-side' believes investors want. To be blunt, I've been disappointed for a while as most "new" ETFs are essentially copies of older and more popular ET...

HATTERSHEIM AM MAIN, Germany , Jan. 24, 2020 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the Danish Medicines Council has published its final decision, approving human Alpha 1 Antitrypsin  (AAT) therapy and Respreeza® as standard treatment for ...

ASLAN Pharmaceuticals (NASDAQ: ASLN ) has amended its license agreement with CSL Limited ( OTCPK:CMXHF ) thereby acquiring full global rights to develop, manufacture and commercialise ASLAN004 in all indications. The amended agreement replaces the original agreement signed in May...

The following slide deck was published by CSL Ltd. ADR in conjunction with their 2018 Q4 earnings Read more ...

The following slide deck was published by CSL Ltd. ADR in conjunction with their 2018 Q2 earnings Read more ...